Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum
Abstract The causal role of abdominal overweight/obesity, insulin resistance and type 2 diabetes (T2D) on the risk of fatty liver disease (FLD) has robustly been proven. A consensus of experts has recently proposed the novel definition of ‘metabolic dysfunction‐associated fatty liver disease, MAFLD’...
Main Authors: | Federica Tavaglione, Giovanni Targher, Luca Valenti, Stefano Romeo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Endocrinology, Diabetes & Metabolism |
Subjects: | |
Online Access: | https://doi.org/10.1002/edm2.179 |
Similar Items
-
What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
by: Giovanni Targher
Published: (2020-10-01) -
The diagnostic conundrum in non-alcoholic fatty liver disease
by: Valerio Rosato, et al.
Published: (2020-10-01) -
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank
by: Federica Tavaglione, et al.
Published: (2021-06-01) -
Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease
by: Alice Emma Taliento, et al.
Published: (2019-08-01) -
Fatty liver: How frequent is it and why?
by: Giorgio Bedogni, et al.
Published: (2004-04-01)